Login

Tomorrow's Company interviews Roger Parry CBE, Chairman of YouGov plc and Oxford Metrics plc, as well as Peter Taylor. 00:10:00

Share On Facebook Share On Twitter

Imogen Moorhouse is CEO/Exec Dir at Oxford Metrics PLC. 

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Provides investment management and advisory services|Tim Collins,CEO,Ripplewood Holding
00:10:00
Alexandre Ostrowiecki on Leading Multi and Transforming Brazilian Tech | Alexandre Ostrowiecki , CEO, Multilaser Industrial SA.
00:10:00
Newport is an Acensus company and Helping millions save for a better future | Charles K. Ortel,Managing Partner of Newport Value Partners, Newport,Allspring Target 2010 CIT E3
00:10:00
Rick Rule on Financial Resilience and Market Insights Amidst Uncertainty
00:10:00
Stephen Schwarzman Discusses Real Estate Opportunities, U.S.-China Relations, and Presidential Politics | Stephen A. Schwarzman, CEO , The Blackstone Group Inc.
00:10:00
improve the health of people and planet.|Harsh Patel,Co-Founder and Managing Partner,Wireframe Ventures
00:10:00
Enhancing Financial Value through Operational Excellence | Seth Brody, Partner, APAX Partners.
00:10:00
First Impressions and Insights from the One-to-One Mining Conference in New York
00:10:00
A2A highlights Andres Acebo and features a CEO spotlight on Priscilla Almodovar joining Fannie Mae as CEO.
00:10:00
Navigating Career Beginnings and Beyond | David Mussafer, Chairman,  Advent International.
00:10:00
Transforming Respiratory Diagnostics: 4D Medical's Innovative Healthcare Journey| Dr Andreas Fouras, CEO, 4dmedical ltd.
00:10:00
Inca One Gold Closes $500K Private Placement with OSUM

© 2017 - Neuhu+